Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
By J. Gabrilove, C. Cleeland, R. Livingston, B. Sarokhan, Eric P. Winer, L. Einhorn. Journal of Clinical Oncology, 2001
613 citations recorded by the source corpus.
Subfields: Biochemistry, Hematology, Immunology
View Paper: https://www.semanticscholar.org/paper/46f64417b8d33b4b49b3e5511617e15441444bb7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- C. Bokemeyer
- P. Barrett-Lee
- J. Nortier
- H. Ludwig
- P. Kosmidis
- P. Olmi
- D. Schrijvers
- P. Gascón
Citations in the corpus
- The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. (2004, background): “To date, information on the prevalence and effects of anaemia have come from clinical trials of anaemia treatments [5,9–12] or cytotoxic agents [13] that present results from protocol-defined patient populations and often have very low haemoglobin definitions for anaemia that are based on blood tran”